Genprex Inc (GNPX) Actualités

Genprex to Participate at BIO Europe Spring 2025

Genprex to Participate at BIO Europe Spring 2025 PR Newswire AUSTIN, Texas, March 4, 2025 AUSTIN, Texas, March...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Genprex Advances Diabetes Program with Addition of Research Focused on Non-Viral Delivery System

Genprex Advances Diabetes Program with Addition of Research Focused on Non-Viral Delivery System PR...

Form 8-K - Current report

Genprex Provides Update on Diabetes Gene Therapy Program

Genprex Provides Update on Diabetes Gene Therapy Program PR Newswire AUSTIN, Texas, Feb. 18, 2025 Signs an...

Genprex Collaborators Find NPRL2 Gene Therapy Using Oncoprex® Delivery System is a Potential Treatment for Anti-PD1 Resistant Non-Small Cell Lung Cancer

Genprex Collaborators Find NPRL2 Gene Therapy Using Oncoprex® Delivery System is a Potential Treatment for...

Form 8-K - Current report

Form S-8 - Securities to be offered to employees in employee benefit plans

Form 8-K - Current report

Genprex Announces First Patient Dosed in Phase 2 Expansion Portion of Acclaim-3 Clinical Study of Reqorsa® Gene Therapy in Combination with Tecentriq® to Treat Small Cell Lung Cancer

Genprex Announces First Patient Dosed in Phase 2 Expansion Portion of Acclaim-3 Clinical Study of Reqorsa®...

Form 8-K - Current report

Genprex to Participate at the 43rd Annual J.P. Morgan Healthcare Conference

Genprex to Participate at the 43rd Annual J.P. Morgan Healthcare Conference PR Newswire AUSTIN, Texas, Jan. 6...

Form 424B5 - Prospectus [Rule 424(b)(5)]

Form 8-K - Current report